Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine

被引：7

作者：

Milazzo, L ^{[1
]}

Rusconi, S

Testa, L

La Seta-Catamancio, S

Galazzi, M

Kurtagic, S

Citterio, P

Gianotto, M

Grassini, A

Adorni, F

d'Arminio-Monforte, A

Galli, M

Moroni, M

机构：

[1] Univ Milan, Osped Luigi Sacco, Ist Malattie Infett & Trop, Milan, Italy

[2] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy

来源：

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1999年 / 22卷 / 01期

关键词：

D O I：

10.1097/00042560-199909010-00013

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：101 / 103

页数：3

共 15 条

[1]

Aber V, 1996, LANCET, V348, P283, DOI 10.1016/S0140-6736(96)05387-1

[2]

Baxter J, 1999, ANTIVIR THER S, V4, P43

[3] Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].

Cameron, DW ;

Heath-Chiozzi, M ;

Danner, S ;

Cohen, C ;

Kravcik, S ;

Maurath, C ;

Sun, E ;

Henry, D ;

Rode, R ;

Potthoff, A ;

Leonard, J .

LANCET, 1998, 351 (9102) :543-549

[4] Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154

[5] Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine [J].

Collier, AC ;

Coombs, RW ;

Schoenfeld, DA ;

Bassett, RL ;

Timpone, J ;

Baruch, A ;

Jones, M ;

Facey, K ;

Whitacre, C ;

McAuliffe, VJ ;

Friedman, HM ;

Merigan, TC ;

Reichman, RC ;

Hooper, C ;

Corey, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) :1011-1017

[6]

Cooper DA, 1997, LANCET, V349, P1413, DOI 10.1016/S0140-6736(97)04441-3

[7] Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial [J].

Durant, J ;

Clevenbergh, P ;

Halfon, P ;

Delgiudice, P ;

Porsin, S ;

Simonet, P ;

Montagne, N ;

Boucher, CAB ;

Schapiro, JM ;

Dellamonica, P .

LANCET, 1999, 353 (9171) :2195-2199

[8] Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection - 100-week follow-up [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Jonas, L ;

Meibohm, A ;

Holder, D ;

Schleif, WA ;

Condra, JH ;

Emini, EA ;

Isaacs, R ;

Chodakewitz, JA ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :35-41

[9] A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter [J].

Hammer, SM ;

Katzenstein, DA ;

Hughes, MD ;

Gundacker, H ;

Schooley, RT ;

Haubrich, RH ;

Henry, WK ;

Lederman, MM ;

Phair, JP ;

Niu, M ;

Hirsch, MS ;

Merigan, TC ;

Blaschke, TF ;

Simpson, D ;

McLaren, C ;

Rooney, J ;

Salgo, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1081-1090

[10] Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy [J].

Iversen, AKN ;

Shafer, RW ;

Wehrly, K ;

Winters, MA ;

Mullins, JI ;

Chesebro, B ;

Merigan, TC .

JOURNAL OF VIROLOGY, 1996, 70 (02) :1086-1090

← 1 2 →